Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues

Trevor J. Pitcher, Vanessa Sarathy, Kiyohiko Matsui, Gregory D. Gromowski, Claire Y H Huang, Alan Barrett

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The dengue virus (DENV) envelope protein domain 3 (ED3) is the target of potent virus neutralizing antibodies. The DENV-2 ED3 contains adjacent type-specific and DENV complex-reactive antigenic sites that are composed of a small number of residues that were previously demonstrated to be critical for antibody binding. Site-directed mutagenesis of a DENV-2 16681 infectious clone was used to mutate critical residues in the DENV-2 type-specific (K305A and P384A) and DENV complex-reactive (K310A) antigenic sites. The K305A mutant virus multiplied like the parent virus in mosquito and mammalian cells, as did the P384A mutant virus, which required a compensatory mutation (G330D) for viability. However, the K310A mutant virus could not be recovered. The DENV-2 type-specific critical residue mutations K305A and P384A+G330D reduced the ability of DENV-2 type-specific, but not DENV complex-reactive, mAbs to neutralize virus infectivity and this was directly correlated with mAb binding affinity to the rED3 mutants.

Original languageEnglish (US)
Pages (from-to)288-293
Number of pages6
JournalJournal of General Virology
Volume96
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Viral Envelope Proteins
Dengue Virus
Epitopes
Viruses
Protein Domains
Mutation
Site-Directed Mutagenesis
Neutralizing Antibodies
Culicidae
Catalytic Domain
Clone Cells

ASJC Scopus subject areas

  • Virology

Cite this

Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues. / Pitcher, Trevor J.; Sarathy, Vanessa; Matsui, Kiyohiko; Gromowski, Gregory D.; Huang, Claire Y H; Barrett, Alan.

In: Journal of General Virology, Vol. 96, No. 2, 01.02.2015, p. 288-293.

Research output: Contribution to journalArticle

@article{554ebffa5fd44a48863910a3fec78702,
title = "Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues",
abstract = "The dengue virus (DENV) envelope protein domain 3 (ED3) is the target of potent virus neutralizing antibodies. The DENV-2 ED3 contains adjacent type-specific and DENV complex-reactive antigenic sites that are composed of a small number of residues that were previously demonstrated to be critical for antibody binding. Site-directed mutagenesis of a DENV-2 16681 infectious clone was used to mutate critical residues in the DENV-2 type-specific (K305A and P384A) and DENV complex-reactive (K310A) antigenic sites. The K305A mutant virus multiplied like the parent virus in mosquito and mammalian cells, as did the P384A mutant virus, which required a compensatory mutation (G330D) for viability. However, the K310A mutant virus could not be recovered. The DENV-2 type-specific critical residue mutations K305A and P384A+G330D reduced the ability of DENV-2 type-specific, but not DENV complex-reactive, mAbs to neutralize virus infectivity and this was directly correlated with mAb binding affinity to the rED3 mutants.",
author = "Pitcher, {Trevor J.} and Vanessa Sarathy and Kiyohiko Matsui and Gromowski, {Gregory D.} and Huang, {Claire Y H} and Alan Barrett",
year = "2015",
month = "2",
day = "1",
doi = "10.1099/vir.0.070813-0",
language = "English (US)",
volume = "96",
pages = "288--293",
journal = "Journal of General Virology",
issn = "0022-1317",
publisher = "Society for General Microbiology",
number = "2",

}

TY - JOUR

T1 - Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues

AU - Pitcher, Trevor J.

AU - Sarathy, Vanessa

AU - Matsui, Kiyohiko

AU - Gromowski, Gregory D.

AU - Huang, Claire Y H

AU - Barrett, Alan

PY - 2015/2/1

Y1 - 2015/2/1

N2 - The dengue virus (DENV) envelope protein domain 3 (ED3) is the target of potent virus neutralizing antibodies. The DENV-2 ED3 contains adjacent type-specific and DENV complex-reactive antigenic sites that are composed of a small number of residues that were previously demonstrated to be critical for antibody binding. Site-directed mutagenesis of a DENV-2 16681 infectious clone was used to mutate critical residues in the DENV-2 type-specific (K305A and P384A) and DENV complex-reactive (K310A) antigenic sites. The K305A mutant virus multiplied like the parent virus in mosquito and mammalian cells, as did the P384A mutant virus, which required a compensatory mutation (G330D) for viability. However, the K310A mutant virus could not be recovered. The DENV-2 type-specific critical residue mutations K305A and P384A+G330D reduced the ability of DENV-2 type-specific, but not DENV complex-reactive, mAbs to neutralize virus infectivity and this was directly correlated with mAb binding affinity to the rED3 mutants.

AB - The dengue virus (DENV) envelope protein domain 3 (ED3) is the target of potent virus neutralizing antibodies. The DENV-2 ED3 contains adjacent type-specific and DENV complex-reactive antigenic sites that are composed of a small number of residues that were previously demonstrated to be critical for antibody binding. Site-directed mutagenesis of a DENV-2 16681 infectious clone was used to mutate critical residues in the DENV-2 type-specific (K305A and P384A) and DENV complex-reactive (K310A) antigenic sites. The K305A mutant virus multiplied like the parent virus in mosquito and mammalian cells, as did the P384A mutant virus, which required a compensatory mutation (G330D) for viability. However, the K310A mutant virus could not be recovered. The DENV-2 type-specific critical residue mutations K305A and P384A+G330D reduced the ability of DENV-2 type-specific, but not DENV complex-reactive, mAbs to neutralize virus infectivity and this was directly correlated with mAb binding affinity to the rED3 mutants.

UR - http://www.scopus.com/inward/record.url?scp=84921730027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921730027&partnerID=8YFLogxK

U2 - 10.1099/vir.0.070813-0

DO - 10.1099/vir.0.070813-0

M3 - Article

C2 - 25351518

AN - SCOPUS:84921730027

VL - 96

SP - 288

EP - 293

JO - Journal of General Virology

JF - Journal of General Virology

SN - 0022-1317

IS - 2

ER -